Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK3486 for induction of general anesthesia
NCT04711837Phase 3Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Feb 2021
- Primary completion
- Apr 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cycloprofol (2 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoint: Number of Participants With Successful Anesthesia Induction up to 5 minutes. Started Feb 2021; status: completed.
02
Drugs
cycloprofol
Beyond the preview
Go deeper on NCT04711837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04711837.